IP Library Granted Patent US 11,266,821
Granted Patent B2
US 11,266,821 · App. 15/874,749 · Granted Mar 8, 2022

Autonomous fluid instillation system and method with tissue site pressure monitoring

Inventors: Benjamin Andrew Pratt (Poole, GB); Christopher Brian Locke (Bournemouth, GB)
Assignee: KCI Licensing, Inc.
A61M37/00A61F13/00068A61M1/85A61M1/90A61M3/022A61M39/22A61M1/0062A61M3/0258A61M3/0283A61M2037/0007A61M2039/226A61M2205/3334A61M2205/3344
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,266,821
App. No.
15/874,749
Granted
Mar 8, 2022
Kind
B2
Abstract

A system and method for providing fluid to a tissue site is described. The method fluidly couples an instillation therapy system to the tissue site and monitors a pressure supplied to the tissue site by a reduced-pressure source with the instillation therapy system for a time period. The method provides fluid to the tissue site with the instillation therapy system in response to the pressure at the tissue site during the time period. The system includes a pressure sensor fluidly coupled to the tissue site to measure a pressure proximate the tissue site. A valve and a flow meter are fluidly between a fluid reservoir and the tissue site. A controller is communicatively coupled to the pressure sensor and the valve and configured to monitor the pressure at the tissue site and a volume of fluid flow to the tissue and, in response, operate the valve.

Claims (23)

1. A system for providing instillation therapy to a tissue site, the system comprising:

a fluid interface configured to be fluidly coupled to the tissue site;

a pressure sensor fluidly coupled to the fluid interface and configured to measure a pressure proximate the tissue site;

a valve fluidly coupled to the fluid interface and having an open position configured to permit fluid communication through the valve and a closed position configured to prevent fluid communication through the valve;

a flow meter configured to be fluidly coupled between the valve and the fluid interface and monitor a fluid flow rate through the valve to determine a volume of fluid flow;

a fluid reservoir fluidly coupled to the valve; and

a controller communicatively coupled to the pressure sensor and the valve, the controller configured to monitor the pressure measured by the pressure sensor and a volume of fluid flow through the flow meter and, in response, operate the valve;

the controller being further configured to open the valve in response to the pressure sensor detecting a predetermined pressure and to close the valve in response to the flow meter determining a predetermined volume of fluid has been delivered to the tissue site.

2. The system of claim 1 , wherein the controller is configured to operate the valve in response to one or more of a maximum reduced pressure, a minimum reduced pressure, a trigger pressure, an on-state and an off-state of a reduced-pressure therapy system, and a duration of fluid delivery and an interval of fluid delivery.

3. The system of claim 1 , wherein the controller is configured to determine a pressure profile in response to the pressure measured by the pressure sensor.

4. The system of claim 3 , wherein the controller is configured to determine one or more operating parameters in response to the pressure profile.

5. The system of claim 4 , wherein the one or more operating parameters comprise one or more of a maximum reduced pressure, a minimum reduced pressure, a trigger pressure, and an on-state and an off-state of a reduced-pressure therapy system.

6. The system of claim 1 , further comprising a user interface operationally coupled to the controller and configured to present one or more operating parameters of the system.

7. The system of claim 6 , wherein the one or more operating parameters comprise one or more of a maximum reduced pressure, a minimum reduced pressure, a trigger pressure, and an on-state and an off-state of a reduced-pressure therapy system.

8. The system of claim 6 , wherein the user interface is further configured to receive operational input and communicate the operational input to the controller.

9. The system of claim 8 , wherein the operational input may comprise one or more of a maximum reduced pressure, a minimum reduced pressure, a trigger pressure, a duration of fluid delivery, and an interval of fluid delivery.

10. The system of claim 1 , further comprising a pump fluidly coupled between the fluid reservoir and the valve, the pump being operationally coupled to the controller.

11. The system of claim 1 , further comprising a disposable connector fluidly coupled between the pressure sensor and the fluid interface.

12. The system of claim 1 , further comprising at least one sensor fluidly coupled to a tube fluidly coupling the valve to the fluid interface and further operationally coupled to the controller, the at least one sensor configured to detect blockages in the tube.

13. The system of claim 1 , further comprising:

a reduced-pressure interface configured to be fluidly coupled to the tissue site;

a reduced-pressure pressure source configured to be fluidly coupled to the reduced-pressure interface; and

a fluid container configured to be fluidly coupled between the reduced-pressure interface and the reduced-pressure source.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0636 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2018
From: PRATT, BENJAMIN ANDREW; LOCKE, CHRISTOPHER BRIAN
To: KCI LICENSING, INC.
Reel/Frame 044662/0152 →